Shamsri Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 30-07-2024
- Paid Up Capital ₹ 0.10 M
as on 30-07-2024
- Company Age 16 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 148.87%
(FY 2023)
- Profit 819.82%
(FY 2023)
- Ebitda 943.64%
(FY 2023)
- Net Worth 45.43%
(FY 2023)
- Total Assets 32.52%
(FY 2023)
About Shamsri Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kumar Surendra and Kumari Binu serve as directors at the Company.
- CIN/LLPIN
U74120DL2008PTC174473
- Company No.
174473
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Feb 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Shamsri Pharma Private Limited offer?
Shamsri Pharma Private Limited offers a wide range of products and services, including Urology Equipment.
Who are the key members and board of directors at Shamsri Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kumar Surendra  | Director | 25-Feb-2008 | Current |
| Kumari Binu | Director | 25-Feb-2008 | Current |
Financial Performance of Shamsri Pharma.
Shamsri Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 148.87% increase. The company also saw a substantial improvement in profitability, with a 819.82% increase in profit. The company's net worth Soared by an impressive increase of 45.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shamsri Pharma?
In 2023, Shamsri Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shamsri Pharma?
Unlock and access historical data on people associated with Shamsri Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shamsri Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shamsri Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
